SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001156175-14-000011
Filing Date
2014-02-12
Accepted
2014-02-12 17:15:19
Documents
1
Group Members
BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 BROOKSIDE 13G FOR IDENIX PHARMACEUTICALS, INC. AS OF DECEMBER 31, 2013 IdenixSC13G.txt SC 13G/A 7364
  Complete submission text file 0001156175-14-000011.txt   8989
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Subject) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79969 | Film No.: 14601384
SIC: 2834 Pharmaceutical Preparations

Mailing Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116
Business Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BROOKSIDE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE
Type: SC 13G/A